Loading clinical trials...

Quality of Life and Efficacy Evaluation of Patient Self-monitoring Their Oral Anticoagulation Therapy | Clinical Trials | Clareo Health

COMPLETEDNA

Quality of Life and Efficacy Evaluation of Patient Self-monitoring Their Oral Anticoagulation Therapy

Evaluation of Self-monitoring of Oral antiCoagulant therApy by the PatiEnts

NCT01033279•Montreal Heart Institute

View on ClinicalTrials.gov

Summary

The purpose of this study is to determine whether self-management of oral anticoagulation therapy with warfarin has an effect on patient's quality of life following a specific training program led by pharmacists.

Eligibility

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patient aged 18 years and over followed at the Montreal Heart Institute's Anticoagulation clinic
•Warfarin treatment planned for at least 4 months after inclusion in the study
•Warfarin treatment initiated for at least 6 months
•Last 2 INRs between 1.5 and 4 if target INR is between 2 and 3
•Last 2 INRS between 2 and 4 if target INR is between 2.5 and 3.5
•Provide a signed informed consent

Exclusion Criteria

•Patient unable to understand (spoken and written) French or English
•Patient refuses or is unable to attend the required training sessions
•Targeted INR other than 2 to 3 or 2.5 to 3.5
•Handicap or physical limitation compromising the patient's ability to initiate self-monitoring in the absence of a proxy helper
•Moderate to severe cognitive impairment or important comprehension problems
•Active neoplasm
•Concurrent chemotherapy
•Hypercoagulable conditions
•Life expectancy of less than 1 year documented in the medical chart
•Inclusion (at time of inclusion or 30 days prior to inclusion) in another research project involving a drug
+6 more criteria

Locations (1)

Montreal Heart Institute

Montreal, Quebec, Canada

Key Dates

Start Date

October 1, 2009

Primary Completion Date

May 1, 2010

Completion Date

May 1, 2010

Last Updated

May 30, 2012

Enrollment

120

ACTUAL participants

Conditions

AnticoagulantsQuality of LifeDrug MonitoringPharmacyAmbulatory Care

Interventions

Self-monitoring and adjustment of oral anticoagulation

OTHER

"Erectile Function After PCI in MI and Non-MI Patients"

NCT07444697

Erectile DisfunctionCoronary Artery Disease (CAD)+3 more

View study

RECRUITINGPHASE3

PRophylaxis Against Early VENTilator-associated Infections in Acute Brain Injury

NCT06819592

All-cause MortalityQuality of Life+5 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 30, 2012Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Quality of Life and Efficacy Evaluation of Patient Self-monitoring Their Oral Anticoagulation Therapy

Inclusion Criteria

Exclusion Criteria

"Erectile Function After PCI in MI and Non-MI Patients"

PRophylaxis Against Early VENTilator-associated Infections in Acute Brain Injury

Predictive Factors for Functional and Quality of Life Decline in Patients >65 Years With a Gastrointestinal Tract Cancer Diagnosis Taken to Curative Resectable Surgery

The PREGNANT (Pregnant Resident Empowerment, GuidaNce, and Advocacy iN Training) Coaching Project

Improving Congenital Heart Disease Care

The Relationship Between Functional Independence and Family Well-being in Children With Rare Genetic Disorders